Analyst Ratings for Sagimet Biosciences Inc (SGMT)
SGMT Rating Summary
SGMT Price Target Summary
- Highest: $56.00 (Canaccord)
- Lowest: $18.00 (Barclays)
- Average: $31.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.38 (+183.7%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$31.38 (+183.7%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Cantor Fitzgerald | Yanni Souroutzidis | New Coverage | Overweight (N/A) |
N/A (N/A) |
10.71 (11.06) |
3.27% | Details |
| 9/9/2026 | Barclays | Eliana Merle | Upgrade | Overweight (Equalweight) |
18.00 (8.00) |
10.94 (11.06) |
1.1% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


